Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Using Surrogate Endpoints to Improve the Design and Analysis of Randomized Screening Trials Yingqi Zhao Fred Hutchinson Cancer Center NLST May 4, 2026 NLST-1511
Foundation LDCT model for lung cancer prediction Daan van den Broek Netherlands Cancer Institute NLST May 4, 2026 NLST-1512
Estimating the intake of moderation foods and evaluating associations with risk of cancer and mortality Kaelyn Burns National Cancer Institute PLCO May 4, 2026 PLCO-2045
Wildfire Smoke Exposure and Cancer- and Aging-Related Outcomes in the PLCO Cohort Shuguang Leng University of New Mexico HSC PLCO Apr 28, 2026 PLCO-2041
Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates (Original Project: PLCO-1091) Hormuzd Katki American Cancer Society PLCO Apr 28, 2026 PLCO-2043
Deep Learning to Improve Screening of Interstitial Lung Diseases Asif Abdul Hameed Henry Ford Health NLST Apr 28, 2026 NLST-1505
Estimating the lung cancer mortality benefit of screening within lung cancer risk strata in the National Lung Screening Trial (Original Project: 201204-0017) Hormuzd Katki American Cancer Society NLST Apr 28, 2026 NLST-1507
Continuation of DCPP (PLCO-286/PLCO-287) Stephanie Smith-Warner Harvard TH Chan School of Public Health PLCO Apr 27, 2026 PLCO-2042
Association between microplastic exposure and risk of never-smoking lung cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Qing Lan National Cancer Institute PLCO Apr 21, 2026 2025-0048
Generalizability of the PLCO Sarah Robertson Dartmouth College PLCO Apr 20, 2026 PLCO-2039
Treatment-Conditioned World Models for Lung Cancer Progression Prediction Using Longitudinal Low-Dose CT Imaging Luca Pegolotti Nucleo Research, Inc. NLST Apr 20, 2026 NLST-1502
Statistical methods to detect and estimate etiologic heterogeneity in epidemiologic studies Anil Chaturvedi National Cancer Institute PLCO Apr 13, 2026 PLCO-2038
Developing an All-cancer Risk Model Paul Pinsky National Institutes of Health PLCO Apr 13, 2026 PLCO-2040
Integrating Early Detection of Heart Disease with Lung Cancer Powered by AI-CXR Morteza Naghavi HeartLung Technologies NLST Mar 31, 2026 NLST-1501
AI-Enabled Opportunistic Detection of Cardiovascular Disease Risk from Chest Radiographs in the PLCO Cohort Morteza Naghavi HeartLung Technologies PLCO Mar 30, 2026 PLCOI-2034
Integrative Genomic, Histologic, and Spatial Profiling of ClonalHematopoiesis in Lung Cancer Janghee Woo Emory University PLCO Mar 30, 2026 PLCOI-2024
Pilot study of circulating immune checkpoint proteins in persons with and without cancer Kara Michels Albert Einstein College of Medicine PLCO Mar 26, 2026 2026-9129
Integrative Analysis of Metabolic Programs Associated with Cancer Risk and Outcomes in the PLCO Cohort Blake Rushing University of North Carolina at Chapel Hill PLCO Mar 26, 2026 PLCO-2035
Clarifying Lung Cancer Risk Among Colorectal Cancer Survivors Juan Wisnivesky Icahn School of Medicine at Mount Sinai PLCO Mar 23, 2026 PLCO-2036
Exposomic and Metabolomic Approaches to Understanding Cancer Risk in Females: A Secondary PLCO Study Jordan Kuiper The George Washington University PLCO Mar 23, 2026 PLCO-2027